sermorelin 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
growth hormone release-stimulating peptides 2433 86168-78-7

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • sermorelin acetate
  • sermorelin
  • somatoliberin
The biologically active fragment of human growth hormone-releasing factor, consisting of GHRH(1-29)-amide. This N-terminal sequence is identical in several mammalian species, such as human, pig, and cattle. It is used to diagnose or treat patients with GROWTH HORMONE deficiency.
  • Molecular weight: 3357.93
  • Formula: C149H246N44O42S
  • CLOGP:
  • LIPINSKI: 3
  • HAC: 86
  • HDO: 52
  • TPSA: 1446.90
  • ALOGS: -4.75
  • ROTB: 115

Drug dosage:

None

ADMET properties:

Approvals:

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Drug Use | Suggest Off label Use Form| |View source of the data|




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

External reference:

Pharmaceutical products:

None

sermorelin